Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

Stock Summary

Top Correlated Resources

MYO


Top 10 Correlated ETFs

MYO


Top 10 Correlated Stocks

MYO


In the News

08:30 04 Oct 2022 MYO

Myomo to Present at the H.C. Wainwright 24th Annual Global Investment Conference

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that management will present at the H.C. Wainwright 24th Annual Global Investment Conference. The Conference is being held September 12 – 14, both virtually and in New York City. Paul Gudonis, chief executive officer, and David Henry, chief financial

02:38 04 Oct 2022 MYO

Myomo, Inc.'s (MYO) CEO Paul Gudonis on Q2 2022 Results - Earnings Call Transcript

Myomo, Inc. (NYSE:MYO ) Q2 2022 Earnings Conference Call August 3, 2022 4:30 PM ET Company Participants Kim Golodetz - Investor Relations, LHA Paul Gudonis - Chief Executive Officer Dave Henry - Chief Financial Officer Conference Call Participants Ben Haynor - Alliance Global Partners Scott Henry - Roth Capital Jim Sidoti - Sidoti & Company Ed Woo - Ascendiant Capital Operator Good day and welcome to the Myomo Incorporated Second Quarter 2022 Earnings Conference Call. All participants will be in a listen-only mode.

08:18 04 Oct 2022 MYO

Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates

Myomo, Inc. (MYO) delivered earnings and revenue surprises of 6.67% and 4.79%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

04:05 04 Oct 2022 MYO

Myomo To Present at the Sidoti Summer Small Cap Virtual Investor Conference

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, Myomo's chairman and chief executive officer, and David Henry, Myomo's chief financial officer, will present and provide a business update at the Sidoti Summer Small Cap Conference, which is being held virtually from June 15 to June

07:38 04 Oct 2022 MYO

Myomo, Inc. (MYO) CEO Paul Gudonis on Q1 2022 Results - Earnings Call Transcript

Myomo, Inc. (NYSE:MYO ) Q1 2022 Results Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Kim Golodetz - IR, LHA Investor Relations Paul Gudonis - Chief Executive Officer Dave Henry - Chief Financial Officer Conference Call Participants Scott Henry - Roth Capital Ben Haynor - Alliance Global Partners Jim Sidoti - Sidoti & Company Paul Nouri - Noble Equity Operator Good afternoon. And welcome to the Myomo Incorporated First Quarter 2022 Earnings Conference Call.

07:34 04 Oct 2022 MYO

Myomo, Inc. (MYO) Reports Q1 Loss, Tops Revenue Estimates

Myomo, Inc. (MYO) delivered earnings and revenue surprises of 24.07% and 35.72%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

08:12 04 Oct 2022 MYO

Myomo, Inc. (MYO) CEO Paul Gudonis on Q4 2021 Results - Earnings Call Transcript

Myomo, Inc. (MYO) CEO Paul Gudonis on Q4 2021 Results - Earnings Call Transcript

06:48 04 Oct 2022 MYO

Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates

Myomo, Inc. (MYO) delivered earnings and revenue surprises of -6.12% and 34.36%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

04:15 04 Oct 2022 MYO

Myomo To Participate in Two March Investor Conferences

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces that management will participate in two investor conferences during March: 34th Annual ROTH Conference, March 13-15, 2022 at The Ritz-Carlton, Laguna Niguel, CA. Management will participate in a “Fireside Chat” on Monday, March 14th at 2:00 p.m. PT and will

08:14 04 Oct 2022 MYO

Myomo: Following The Same Path With Less Cash

Myomo has a great deal of similarities in business strategy to its technological & industry peers in terms of markets, joint ventures, and insurance reimbursements. However, its cash position is much weaker, and will quite likely need to raise additional capital before the end of 2022.

Financial details

Company Rating
Neutral
Market Cap
11.34M
Income
-11.15M
Revenue
15.96M
Book val./share
1.49
Cash/share
1.48
Dividend
-
Dividend %
-
Employees
87
Optionable
No
Shortable
Yes
Earnings
08 Nov 2022
P/E
-1.01
Forward P/E
-
PEG
0.19
P/S
0.7
P/B
1.08
P/C
1.06
P/FCF
-1.22
Quick Ratio
2.98
Current Ratio
3.43
Debt / Equity
0.03
LT Debt / Equity
0.03
-
-
EPS (TTM)
-1.71
EPS next Y
-
EPS next Q
-
EPS this Y
-48.5%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-53.6%
Revenue last 5Y
-100%
Revenue Q/Q
-4.92%
EPS Q/Q
2.44%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-33.33%
Inst Own
26.27%
Inst Trans
-6.09%
ROA
-77%
ROE
-86%
ROC
-0.97%
Gross Margin
71%
Oper. Margin
-65%
Profit Margin
-70%
Payout
-
Shs Outstand
7M
Shs Float
5.11M
-
-
-
-
Target Price
-
52W Range
1.58-14.35
52W High
-88.79%
52W Low
+57%
RSI
34
Rel Volume
0.52
Avg Volume
45.41K
Volume
23.55K
Perf Week
-7.65%
Perf Month
-14.21%
Perf Quarter
-59.64%
Perf Half Y
-61.23%
-
-
-
-
Beta
1.04115
-
-
Volatility
0.05%, 0.11%
Prev Close
-3.09%
Price
1.57
Change
-2.48%

Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
10.835.966.922.280
Net income per share
-84.05-25.18-19.33-3.470
Operating cash flow per share
-42.75-23.44-18.66-2.71-1.64
Free cash flow per share
-43.22-23.75-18.75-2.73-1.69
Cash per share
90.0415.968.063.682.66
Book value per share
86.4715.683.293.472.64
Tangible book value per share
86.4715.683.293.472.6
Share holders equity per share
86.4715.683.293.472.64
Interest debt per share
004.790.720.13
Market cap
19.08M20.9M4.82M35.3M39.65M
Enterprise value
6.13M14.36M3.01M24.97M24.86M
P/E ratio
-1.58-2.03-0.45-3.050
Price to sales ratio
12.248.551.264.650
POCF ratio
-3.1-2.18-0.47-3.91-4.15
PFCF ratio
-3.07-2.15-0.46-3.89-4.02
P/B Ratio
1.533.252.643.052.57
PTB ratio
1.533.252.643.052.57
EV to sales
3.935.870.783.290
Enterprise value over EBITDA
-0.51-1.4-0.28-2.270
EV to operating cash flow
-1-1.49-0.29-2.76-2.6
EV to free cash flow
-0.98-1.47-0.29-2.75-2.52
Earnings yield
-0.63-0.49-2.22-0.330
Free cash flow yield
-0.33-0.47-2.16-0.26-0.25
Debt to equity
000.490.010.03
Debt to assets
0.110.220.720.210.24
Net debt to EBITDA
1.070.640.170.940
Current ratio
9.324.241.585.034.48
Interest coverage
000-22.120
Income quality
0.510.930.970.780
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
3.754.263.011.820
Research and developement to revenue
1.120.750.560.220
Intangibles to total assets
00000
Capex to operating cash flow
0.010.010.010.010
Capex to revenue
-0.04-0.05-0.01-0.010
Capex to depreciation
-5.87-1.82-0.55-0.420
Stock based compensation to revenue
0.180.330.240.080
Graham number
404.494.2637.8316.470
ROIC
-0.52-1.64-3.98-0.89-0.66
Return on tangible assets
-0.87-1.25-1.62-0.790
Graham Net
81.6612.450.413.052.18
Working capital
12.36M6.02M2.27M11.58M14.9M
Tangible asset value
00000
Net current asset value
12.32M6.02M1.38M11.3M14.5M
Invested capital
001.450.170.05
Average receivables
610.98K653.59K674.6K924.92K1.44M
Average payables
222.69K303.61K315.3K180.5K2.07M
Average inventory
454.13K481.63K573.32K707.11K757.71K
Days sales outstanding
69.5557.0940.3544.520
Days payables outstanding
191.35213.87179.0425.340
Days of inventory on hand
145.31128.38174.8399.250
Receivables turnover
5.256.399.058.20
Payables turnover
1.911.712.0414.410
Inventory turnover
2.512.842.093.680
ROE
-0.97-1.61-5.87-10
Capex per share
-0.47-0.31-0.09-0.010

Quarterly Fundamentals Overview

Last date of statement is 2022-06-30 for Q2

Metric History 2021-06-302021-09-302021-12-312022-03-31 2022-06-30
Revenue per share
0.550.770.620.560.53
Net income per share
-0.46-0.36-0.52-0.41-0.42
Operating cash flow per share
-0.6-0.390-0.34-0.38
Free cash flow per share
-0.64-0.4-0.28-0.34-0.39
Cash per share
2.442.222.371.881.48
Book value per share
2.452.312.351.871.49
Tangible book value per share
2.452.312.311.871.49
Share holders equity per share
2.452.312.351.871.49
Interest debt per share
0.160.140.110.130.11
Market cap
60.91M67.55M44.82M26.24M11.63M
Enterprise value
48.02M55.72M30.03M14.16M2.16M
P/E ratio
-5.81-8.21-3.32-2.33-1
Price to sales ratio
19.6215.4111.126.783.16
POCF ratio
-17.93-30.570-11.3-4.39
PFCF ratio
-16.92-29.83-24.19-11.06-4.31
P/B Ratio
4.415.142.912.041.12
PTB ratio
4.415.142.912.041.12
EV to sales
15.4712.717.453.660.59
Enterprise value over EBITDA
-18.93-28.82-8.98-5.41-0.78
EV to operating cash flow
-14.14-25.220-6.1-0.82
EV to free cash flow
-13.34-24.6-16.21-5.97-0.8
Earnings yield
-0.04-0.03-0.08-0.11-0.25
Free cash flow yield
-0.06-0.03-0.04-0.09-0.23
Debt to equity
0.040.040.030.040.03
Debt to assets
0.220.250.240.280.29
Net debt to EBITDA
5.086.124.424.623.41
Current ratio
5.174.424.483.573.43
Interest coverage
-431.98-500.68-526.13.47K-691.5
Income quality
1.31.0700.830.91
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
0.190.150.20.170.17
Intangibles to total assets
00000
Capex to operating cash flow
0.060.0200.020.02
Capex to revenue
-0.07-0.010-0.01-0.01
Capex to depreciation
-3.24-0.570-0.41-0.39
Stock based compensation to revenue
0.120.0700.070.09
Graham number
5.064.345.224.153.76
ROIC
-0.18-0.15-0.17-0.21-0.27
Return on tangible assets
-0.15-0.12-0.17-0.16-0.2
Graham Net
1.971.811.941.41.11
Working capital
13.41M12.74M14.9M11.95M9.42M
Tangible asset value
00000
Net current asset value
12.73M12.15M14.5M11.5M9.09M
Invested capital
0.060.060.050.070.07
Average receivables
1.41M1.95M1.83M1.69M1.53M
Average payables
813.41K819.34K2.48M1.01M936.93K
Average inventory
878.7K836.45K918.54K1.03M1.14M
Days sales outstanding
32.8245.4943.7539.3833.22
Days payables outstanding
61.1450.61390.9970.7761.06
Days of inventory on hand
72.7452.2280.0271.7889.57
Receivables turnover
2.741.982.062.292.71
Payables turnover
1.471.780.231.271.47
Inventory turnover
1.241.721.121.251
ROE
-0.19-0.16-0.22-0.22-0.28
Capex per share
-0.04-0.010-0.01-0.01

Frequently Asked Questions

What is Myomo, Inc. stock symbol ?

Myomo, Inc. is a US stock , located in Cambridge of Massachusetts and trading under the symbol MYO

What is Myomo, Inc. stock quote today ?

Myomo, Inc. stock price is $1.57 today.

Is Myomo, Inc. stock public?

Yes, Myomo, Inc. is a publicly traded company.

Something similar

Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap